APC	antigen-presenting cell
APM	antigen processing machinery
ARID2	AT-rich interaction domain 2
BK1	humane polyomavirus 1
CD	cluster of differentiation
CLA	cutaneous lymphocyte-associated antigen
CR	complete response
CTLA-4	cytotoxic T lymphocyte associated protein 4
DC	dendritic cell
ER	early region
FDA	Food and Drug Administration
G6PD	glucose-6-phosphate dehydrogenase
G100	glucopyranosyl lipid
HDAC	histone deacytelases
HLA	human leucocyte antigen
ICI	immune checkpoint inhibitor
IDO	Indolamine-2,3-dioxygenase
IFN	Interferon
IL	Interleukine
Ipi	Ipilimumab
irAEs	Immune-related adverse events
JC	John Cunningham virus
LAG3	lymphocyte activation gene 3
LPS	Lipopolysaccharide
LR	late region
LTA	large T-cell antigen
MCC	Merkel cell carcinoma
MCPyV	Merkel cell polyomavirus
MDSC	myeloid-derived suppressor cells
MHC	major histocompatibility complex
mMCC	metastatic Merkel cell carcinoma
Nivo	Nivolumab
NO	nitrogen oxide
NTRK1	neurotrophic receptor tyrosine kinase 1
PBMC	peripheral mononuclear blood cells
pCR	pathological complete response
PD-1	programmed cell death protein 1
PD-L1	programmed cell death ligand 1
PML	pro-myelocytic leukaemia
RB1	retinoblastoma protein 1
SSNV	somatic single nucleotide variants
STA	small T-cell antigen
STING	stimulator of interferon genes
TAM	tumour-associated macrophages
Tcm	central memory T-cell
TCR	T-cell receptor
Tfh	T follicular helper cell
TDO	tryptophan-2,3-dioxygenase
TIGIT	T-cell immunoreceptor with Ig and ITIM domains
TIL	tumour-infiltrating lymphocyte
TIM-3	T-cell immunoglobulin and mucin domain-containing protein 3
TLR	Toll-like-receptor
TLS	Tertiary lymphoid structures
TMB	Tumour mutational burden
TME	Tumour microenvironment
TP53	tumour protein p53
Treg	regulatory T-cell